Ingredion
Coverage of Ingredion in the Nexus archive.
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion, which could result in nearly 500 jobs being at risk globally. The deal represents a significant loss for London's struggling stock market.
- Tate & Lyle agrees £2.7bn takeover by US rival in new blow to London market
Tate & Lyle, a UK-based company producing artificial sweeteners like Splenda, has agreed to a £2.7bn takeover by US rival Ingredion. The deal, valued at 615p per share (60% above pre-takeover prices), could jeopardize nearly 500 global jobs and marks another setback for London's struggling stock market.
- Tate & Lyle agrees to £2.7bn takeover from US rival Ingredion
Tate & Lyle has agreed to a £2.7bn takeover by US rival Ingredion. The deal occurs as the UK-based ingredients company faces challenges from weak consumer spending.
- Ingredion Is in Advanced Talks to Acquire Tate & Lyle for £2.7 billion
Ingredion is in advanced talks to acquire Tate & Lyle for £2.7 billion. Tate & Lyle produces a range of ingredients used in baked goods and animal feed.
- Tate & Lyle Gets Up to £2.7 Billion Offer From Ingredion
Tate & Lyle has received an offer of up to £2.7 billion from Ingredion. The company produces ingredients used in various products, including baked goods and animal feed. This offer is a significant development for Tate & Lyle.